47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10 - Warehousing and storage of goods
68.20.Z - Rental and management of own or leased real estate
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,6 | 0,4 | -29,6 |
Gross profit (loss) | 0,5 | 0,6 | 0,5 | -17,7 |
EBITDA | 0,6 | 0,6 | 0,5 | -19,8 |
Short time liabilities | 0,6 | 0,9 | 1 | 11,2 |
Other operating costs | 0 | 0 | 0 | -38,2 |
Equity capital | 0,5 | 1 | 1,5 | 46,1 |
Operating profit (EBIT) | 0,6 | 0,6 | 0,5 | -20,3 |
Assets | 2,3 | 3,2 | 3,8 | 19,1 |
Net profit (loss) | 0,5 | 0,6 | 0,5 | -17,3 |
Cash | 0,5 | 1,4 | 1,1 | -20,3 |
Liabilities and provisions for liabilities | 1,9 | 2,2 | 2,3 | 6,5 |
Net income from sale | 11,2 | 12,7 | 14,4 | 12,9 |
Working assets | 2,2 | 3,1 | 3,8 | 20,4 |
Other income costs | 0,3 | 0 | 0,1 | 83,4 |
Depreciation | 0 | 0 | 0 | -2,5 |
% | % | % | p.p. | |
Profitability of capital | 110,6 | 55,7 | 31,5 | -24,2 |
Equity capital to total assets | 19,7 | 31,9 | 39,2 | 7,3 |
Gross profit margin | 4,8 | 4,5 | 3,3 | -1,2 |
EBITDA Margin | 5,4 | 5 | 3,6 | -1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 26 | 26 | 0 |
Current financial liquidity indicator | 3.9258432388305664 | 3.4461095333099365 | 3.7330055236816406 | 0,3 |
Net dept to EBITDA | 1.4094762802124023 | -0.12386974692344666 | 0.38890305161476135 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane